Whereabouts of two scientists fired from Winnipeg virus lab for possible national-security issues shrouded in mystery headtopics.com/ca/whereabouts…
Four months before the couple was expelled from the lab, access-to-information documents show that Dr. Qiu played a key role in shipping two exceptionally virulent viruses – Ebola and Henipah – to China’s Wuhan facility.
The decision to grant access is made by the Public Health Agency of Canada,” CSIS spokesperson Keira Lawson said in an e-mail.Dr. Qiu’s name appears as a co-author on more than 120 scientific research papers between 2000 and 2021.
A significant number of papers were in collaboration with Chinese scientists where research was funded by Chinese government bodies.Other scientific papers she helped author contained research that was funded in part by
the U.S. Department of Homeland Security and the Pentagon’s Defence Threat Reduction Agency.
Former CSIS director Richard Fadden said he does not understand how the students and the PLA researcher managed to gain access to the Winnipeg lab

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with Navroop Singh

Navroop Singh Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @NavroopSingh_

10 Jun
Summary of Various studies on Vaccines & on various strains of SARS-Cov-2 :
Original SARS-CoV-2 strain from Wuhan

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection - Nature Peer reviewed study of 17th May 2021
Nature Study on Original Wuhan Strain of SARS-CoV-2

>Novovax (Protein Sub Unit Vax Tops) - 98%
> Pfizer & Moderna - 95% after 2 Doses
> Sputnik - 95% 2 Doses
> COVAXIN - 80% 2 Doses
> AstraZeneca- 78% {2 doses after 8 weeks, post 12 weeks 90%]
> SINOVAC - 55% after 2 Doses Image
Read 27 tweets
9 Jun
First-dose ChAdOx1 (COVIDSHIELD) and BNT162b2 (Pfizer) COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

first dose of ChAdOx1 was found to be associated with small increased risks of ITP, with suggestive evidence of an increased risk of arterial thromboembolic and hemorrhagic events.
The attenuation of effect found in the SCCS analysis means that there is the potential for overestimation of the reported results, which might indicate the presence of some residual confounding or confounding by indication.
Read 5 tweets
9 Jun
SARS-CoV-2 and the Secret of the Furin Site
The SARS-CoV-2 high infectivity is due to the functional polybasic furin cleavage site in the S protein. How it was acquired is unknown. There are two challenges to face: (i) an evolutionary model, to fit the origin of the coronavirus; and (ii) a molecular mechanism for the site
Here we show genomic fingerprints which are specific of Pangolin-CoVs, Bat-SARS-like (CoVZC45, CoVZXC21), bat RatG13 and human SARS-CoV-2 coronaviruses.
Read 9 tweets
8 Jun
Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of BBV152 vaccine (COVAXIN)
The two-dose vaccine regimen significantly boosted the IgG titer and neutralizing efficacy against both B. and D614G variants compared to that seen with natural infection.
The study demonstrated 1.92 and 1.09 fold reductions in the neutralizing titer against B. variant in comparison with prototype D614G variant with sera of vaccine recipients and natural infection respectively.
Read 4 tweets
8 Jun
Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152 - COVAXIN
Several studies have demonstrated the reduction in the naturalisation efficacy of the SERA of naturally infected and individuals vaccinated with BBIP-CorV (1.6x) - Sinopharm, BNT162b2 (6.5X) - Pfizer, m-RNA1273 (8.6X) - Moderna, ChAdOx1 nCOV (86X) - COVIDSHIELD against B.1.351.
Reduced Naturalisation with the Vaccine Sera of BNT162b2 mRNA (7X) & one dose of ChAdOx1 nCov-19 was observed against B.1.617.2 Delta Variant.
Read 11 tweets
7 Jun
Are u a Virologist. Are u Biologist. Are u a Vaccineologists. I am an educated person who have read extensively read research papers on SARS COV 2 as well as Vaccine Trials and i state on TL various researches. As discussed o. space even doctors appreciated the effort put on TL.
Also one day u find study saying COVIDSHIELD better response than COVAXIN, other day there was Nature Medical Journal Article stating reverse. The other day we hear studies on how Spike Protein based Vaccines get neutralised on Mutants & need constant upgrades.
I share Various research on my TL. I was even advised by learned people to continue this trend & disseminate scientific information, while stating limitations, conflict of interest which is so stated in every Vaccine study to give a correct perspective. Rest is upto readers.
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!